One Touch Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.15 Cr
as on 31-10-2024
- Paid Up Capital ₹ 1.78 Cr
as on 31-10-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.43 Cr
as on 31-10-2024
- Revenue %
(FY 2023)
- Profit -797.58%
(FY 2023)
- Ebitda -927.14%
(FY 2023)
- Net Worth 5833.33%
(FY 2023)
- Total Assets 73.94%
(FY 2023)
About One Touch Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.15 Cr and a paid-up capital of Rs 1.78 Cr.
The company currently has active open charges totaling ₹5.43 Cr.
Raj Choudhary and Sushma Choudhary serve as directors at the Company.
- CIN/LLPIN
U85300BR2020PTC046628
- Company No.
046628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at One Touch Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Choudhary  | Director | 04-Jul-2020 | Current |
| Sushma Choudhary | Director | 04-Jul-2020 | Current |
Financial Performance of One Touch Pharmaceuticals.
One Touch Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 797.58% decrease in profit. The company's net worth Soared by an impressive increase of 5833.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of One Touch Pharmaceuticals?
Unlock access to One Touch Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
One Touch Medical Products Private LimitedActive 17 years 9 monthsRaj Choudhary and Sushma Choudhary are mutual person
R R Medical Enterprises Private LimitedActive 12 years 10 monthsRaj Choudhary and Sushma Choudhary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 Jun 2023 | ₹5.43 Cr | Open |
How Many Employees Work at One Touch Pharmaceuticals?
One Touch Pharmaceuticals has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of One Touch Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped One Touch Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
